MARKET

DYAI

DYAI

Dyadic Intl Inc Del
NASDAQ
0.8000
+0.0324
+4.22%
Closed 19:56 03/09 EDT
OPEN
0.7740
PREV CLOSE
0.7676
HIGH
0.8299
LOW
0.7520
VOLUME
310.30K
TURNOVER
0
52 WEEK HIGH
1.550
52 WEEK LOW
0.7110
MARKET CAP
28.95M
P/E (TTM)
-3.3741
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DYAI last week (0302-0306)?
Weekly Report · 1d ago
Dyadic International Establishes At-the-Market Equity Offering Program
TipRanks · 3d ago
Dyadic International, Fermbox Bio launch of RNase-Free
TipRanks · 5d ago
Dyadic Applied BioSolutions Announces Commercial Launch Of Animal-Origin-Free Recombinant DNase I
Benzinga · 5d ago
Dyadic and Fermbox Bio Launch Animal-Origin-Free Recombinant DNase I (RNase-Free)
Reuters · 5d ago
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
Barchart · 6d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC), Dyadic International (DYAI) and Bioventus (BVS)
TipRanks · 03/02 15:50
Dyadic International, Inzymes announce planned 2026 commercialization
TipRanks · 03/02 12:33
More
About DYAI
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Webull offers Dyadic International Inc stock information, including NASDAQ: DYAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DYAI stock methods without spending real money on the virtual paper trading platform.